AskTheDate.com
Back to calendar

Kalaris Therapeutics, Inc. (KLRS) Earnings

KLRS reports earnings on Wednesday, August 19, 2026

earnings report
August 19, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.49
Actual EPS: $-0.46
EPS surprise: 12.10%
Company overview
Market Cap$74.2M
PriceUSD 3.40
EPS (TTM)-2.14
52-week high11.88
52-week low2.14
SectorHealth Technology
IndustryBiotechnology
Employees20